Medications starting with
Poland-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC code: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC code: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC code: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is intended for adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC code: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC code: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC code: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC code: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicinal product is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC code: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC code: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC code: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC code: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC code: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC code: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC code: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC code: L04AX04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC code: L04AX04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC code: L04AX04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC code: L04AX04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC code: L04AX04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC code: L04AX04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is intended for adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC code: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC code: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC code: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC code: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC code: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC code: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC code: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC code: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC code: L04AX04
Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC code: L04AX04
Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH Synthon B.V. Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC code: L04AX04
Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC code: L04AX04
Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH Synthon B.V. Synthon Hispania S.L.